▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3110 by analyst upside · 2026-11-13
RXST
RxSight, Inc.
Healthcare · Market Cap $226M · P/E 0x
ANALYST PRICE TARGET
+13.4%
implied upside to consensus target
Current Price $5.38
Consensus Target $6.1
Bull Target $8.0
Bear Target $5.0
Analysts Covering 8
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
0
Hold
6
Sell
1
52-Week Low $4.11
52-Week High $13.22
YTD Return -48.2%
FUNDAMENTALS
Market Cap $226M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.29
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $122M
Profit Margin -43.8%
52-WEEK RANGE
52-Week Low $4.11
52-Week High $13.22
Current Price $5.38
Bear Target $5.0
Bull Target $8.0
● Now $5.38 ● Target $6.1
TRADING DATA
Avg Volume 824K
YTD Return -48.2%
Analyst Count 8
Consensus Hold
Upside to Target +13.4%
Last Updated 2026-11-13

ANALYST SUMMARY

RxSight, Inc. (RXST) is currently trading at $5.38 with a Wall Street consensus price target of $6.1, implying potential upside of 13.4% over the next 12 months. 8 analysts currently cover RXST, with a consensus rating of Hold - 12% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.0, while the most cautious has a target of $5.0.

RXST operates in the Healthcare sector with a market capitalisation of $226M. The stock is down 48.2% year-to-date and is currently trading near the lower end of its 52-week range of $4.11 – $13.22.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PDEX +9.8%
Pro-Dex, Inc.
$216M · P/E 18.6x · Buy
CYH +19.1%
Community Health Systems, Inc.
$312M · P/E 8.8x · Hold
ORMP +73.7%
Oramed Pharmaceuticals Inc.
$168M · P/E 1.0x · Hold
ELMD +94.2%
Electromed, Inc.
$204M · P/E 18.1x · Buy
INFU +25.1%
InfuSystem Holdings, Inc.
$296M · P/E 32.9x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for RXST, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Piper Sandler - Reiterated
Neutral → Neutral 2026-11-04 14% win rate (7 calls)
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-11-04 Building track record
Needham - Reiterated
Buy → Buy 2026-11-04 20% win rate (5 calls)
Jefferies - Reiterated
Hold → Hold 2026-09-22 50% win rate (6 calls)
B of A Securities - Reiterated
Underperform → Underperform 2026-09-22 Building track record
Stifel - Reiterated
Hold → Hold 2026-08-10 Building track record
UBS - Reiterated
Neutral → Neutral 2026-08-06 33% win rate (6 calls)
B of A Securities - Reiterated
Underperform → Underperform 2026-07-07 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
38
out of 100
Coverage depth
17/30
Consensus clarity
19/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →